Market Tracker

07/31 5:16pm ET

Enzon Pharmaceuticals Inc (NASDAQ:ENZN)

1.07
Data as of 3:59pm ET
 -0.02 / -1.83%
Today’s Change
0.78
Today|||52-Week Range
1.50
-7.76%
Year-to-Date
No recent news for Enzon Pharmaceuticals Inc.

Today’s Trading

Previous close1.09
Today’s open1.10
Day’s range1.06 - 1.10
Volume178,713
Average volume (3 months)539,647
Market cap$48.1M
Dividend yield--
Data as of 3:59pm ET, 07/31/2014

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-241.48%
Earnings growth (next 5 years)+53.00%
Revenue growth (last year)-19.03%
P/E ratio2.1
Price/Sales1.47
Price/Book9.14

Competitors

 Today’s
change
Today’s
% change
MNOVMediciNova Inc+0.02+0.94%
NBYNovaBay Pharmaceutic...+0.08+8.51%
CDXICardax Inc0.000.00%
REPHRecro Pharma Inc+0.20+3.36%
Data as of 4:00pm ET, 07/31/2014

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$34.5M
Annual profit (last year)$18.2M
Net profit margin52.62%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive &
Operating Officer
George W. Hebard
Chief Financial Officer &
Vice President-Finance
Richard L. Feinstein
Corporate headquarters
Piscataway, New Jersey

Forecasts